Celltrion Earnings Jump: Profit Growth Signals Upside Celltrion is rated Buy as revenue rose 45% and net profit jumped 505% YoY, signaling strong operating leverage, with targets implying upside. Key risks: profit normalization and biosimilar competition. 2026년 10월 09일 English
